IBDEI0SM ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14102,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14102,1,4,0)
 ;;=4^CA Brain
 ;;^UTILITY(U,$J,358.3,14102,1,5,0)
 ;;=5^191.9
 ;;^UTILITY(U,$J,358.3,14102,2)
 ;;=^267279
 ;;^UTILITY(U,$J,358.3,14103,0)
 ;;=200.10^^85^876^44
 ;;^UTILITY(U,$J,358.3,14103,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14103,1,4,0)
 ;;=4^Lymphoma,Int or High Grade,Uns
 ;;^UTILITY(U,$J,358.3,14103,1,5,0)
 ;;=5^200.10
 ;;^UTILITY(U,$J,358.3,14103,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,14104,0)
 ;;=200.20^^85^876^43
 ;;^UTILITY(U,$J,358.3,14104,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14104,1,4,0)
 ;;=4^Lymphoma,Burkitt's,Unspec
 ;;^UTILITY(U,$J,358.3,14104,1,5,0)
 ;;=5^200.20
 ;;^UTILITY(U,$J,358.3,14104,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,14105,0)
 ;;=201.90^^85^876^40
 ;;^UTILITY(U,$J,358.3,14105,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14105,1,4,0)
 ;;=4^Hodgkin's Lymphoma,Unspec Type
 ;;^UTILITY(U,$J,358.3,14105,1,5,0)
 ;;=5^201.90
 ;;^UTILITY(U,$J,358.3,14105,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,14106,0)
 ;;=202.00^^85^876^45
 ;;^UTILITY(U,$J,358.3,14106,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14106,1,4,0)
 ;;=4^Lymphoma,Low-Grade,Unspec Site
 ;;^UTILITY(U,$J,358.3,14106,1,5,0)
 ;;=5^202.00
 ;;^UTILITY(U,$J,358.3,14106,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,14107,0)
 ;;=202.40^^85^876^39
 ;;^UTILITY(U,$J,358.3,14107,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14107,1,4,0)
 ;;=4^Hairy Cell Leukemia,Unspec
 ;;^UTILITY(U,$J,358.3,14107,1,5,0)
 ;;=5^202.40
 ;;^UTILITY(U,$J,358.3,14107,2)
 ;;=^69587
 ;;^UTILITY(U,$J,358.3,14108,0)
 ;;=203.00^^85^876^48
 ;;^UTILITY(U,$J,358.3,14108,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14108,1,4,0)
 ;;=4^Multiple Myeloma w/o Rem
 ;;^UTILITY(U,$J,358.3,14108,1,5,0)
 ;;=5^203.00
 ;;^UTILITY(U,$J,358.3,14108,2)
 ;;=^336847
 ;;^UTILITY(U,$J,358.3,14109,0)
 ;;=203.01^^85^876^47
 ;;^UTILITY(U,$J,358.3,14109,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14109,1,4,0)
 ;;=4^Multiple Myeloma in Rem
 ;;^UTILITY(U,$J,358.3,14109,1,5,0)
 ;;=5^203.01
 ;;^UTILITY(U,$J,358.3,14109,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,14110,0)
 ;;=204.00^^85^876^2
 ;;^UTILITY(U,$J,358.3,14110,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14110,1,4,0)
 ;;=4^ALL w/o Remission
 ;;^UTILITY(U,$J,358.3,14110,1,5,0)
 ;;=5^204.00
 ;;^UTILITY(U,$J,358.3,14110,2)
 ;;=^336850
 ;;^UTILITY(U,$J,358.3,14111,0)
 ;;=204.01^^85^876^1
 ;;^UTILITY(U,$J,358.3,14111,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14111,1,4,0)
 ;;=4^ALL in Remission
 ;;^UTILITY(U,$J,358.3,14111,1,5,0)
 ;;=5^204.01
 ;;^UTILITY(U,$J,358.3,14111,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,14112,0)
 ;;=204.10^^85^876^36
 ;;^UTILITY(U,$J,358.3,14112,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14112,1,4,0)
 ;;=4^CLL w/o Remission
 ;;^UTILITY(U,$J,358.3,14112,1,5,0)
 ;;=5^204.10
 ;;^UTILITY(U,$J,358.3,14112,2)
 ;;=^336851
 ;;^UTILITY(U,$J,358.3,14113,0)
 ;;=204.11^^85^876^35
 ;;^UTILITY(U,$J,358.3,14113,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14113,1,4,0)
 ;;=4^CLL in Remission
 ;;^UTILITY(U,$J,358.3,14113,1,5,0)
 ;;=5^204.11
 ;;^UTILITY(U,$J,358.3,14113,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,14114,0)
 ;;=205.00^^85^876^3
 ;;^UTILITY(U,$J,358.3,14114,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14114,1,4,0)
 ;;=4^AMI w/o Remission
 ;;^UTILITY(U,$J,358.3,14114,1,5,0)
 ;;=5^205.00
 ;;^UTILITY(U,$J,358.3,14114,2)
 ;;=^336855
 ;;^UTILITY(U,$J,358.3,14115,0)
 ;;=205.01^^85^876^4
 ;;^UTILITY(U,$J,358.3,14115,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14115,1,4,0)
 ;;=4^AML in Remission
 ;;^UTILITY(U,$J,358.3,14115,1,5,0)
 ;;=5^205.01
